[Present status of the regulation of physiological fibrinolysis. Therapeutic prospects of lys-plasminogen].
D004359:Drug Therapy, Combination; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D007866:Leg / Q000098:blood supply; D009203:Myocardial Infarction / Q000188:drug therapy; D010446:Peptide Fragments / Q000627:therapeutic use*; D010958:Plasminogen / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D010446:Peptide Fragments; C018998:lysyl-plasminogen; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator
Actualités sur la régulation de la fibrinolyse physiologique. Perspectives thérapeutiques du lys-plasminogène.